Suyash M. Patil

628 total citations
14 papers, 470 citations indexed

About

Suyash M. Patil is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Suyash M. Patil has authored 14 papers receiving a total of 470 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 4 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Suyash M. Patil's work include Inhalation and Respiratory Drug Delivery (9 papers), Nanoparticle-Based Drug Delivery (4 papers) and Antimicrobial Peptides and Activities (3 papers). Suyash M. Patil is often cited by papers focused on Inhalation and Respiratory Drug Delivery (9 papers), Nanoparticle-Based Drug Delivery (4 papers) and Antimicrobial Peptides and Activities (3 papers). Suyash M. Patil collaborates with scholars based in United States, Taiwan and India. Suyash M. Patil's co-authors include Nitesh K. Kunda, Vivek Gupta, Aishwarya Saraswat, Manali Patki, Richa Vartak, Ketan Patel, Krutika Sawant, Kan Kaneko, Imran Saleem and Sandip S. Chavhan and has published in prestigious journals such as International Journal of Molecular Sciences, International Journal of Pharmaceutics and Pharmaceutical Research.

In The Last Decade

Suyash M. Patil

14 papers receiving 462 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Suyash M. Patil United States 10 257 110 75 74 72 14 470
Wassana Wijagkanalan Thailand 14 294 1.1× 93 0.8× 72 1.0× 82 1.1× 24 0.3× 22 669
Domizia Baldassi Germany 10 262 1.0× 175 1.6× 74 1.0× 78 1.1× 24 0.3× 12 474
Yingshan Qiu Hong Kong 11 366 1.4× 256 2.3× 57 0.8× 63 0.9× 37 0.5× 16 577
Mary E. Neville United States 13 301 1.2× 249 2.3× 57 0.8× 89 1.2× 52 0.7× 20 795
Cheng‐mei Tian China 13 316 1.2× 29 0.3× 52 0.7× 24 0.3× 100 1.4× 24 534
Franziska Leifer United States 7 255 1.0× 131 1.2× 94 1.3× 47 0.6× 16 0.2× 12 493
Galoz Kaneti Israel 9 184 0.7× 43 0.4× 112 1.5× 19 0.3× 43 0.6× 10 347
Min‐zheng Zhu China 13 300 1.2× 25 0.2× 52 0.7× 24 0.3× 93 1.3× 18 491
Roshan Goswami United States 6 237 0.9× 29 0.3× 49 0.7× 79 1.1× 29 0.4× 7 369
Gui Huang China 11 297 1.2× 23 0.2× 87 1.2× 94 1.3× 126 1.8× 19 496

Countries citing papers authored by Suyash M. Patil

Since Specialization
Citations

This map shows the geographic impact of Suyash M. Patil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suyash M. Patil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suyash M. Patil more than expected).

Fields of papers citing papers by Suyash M. Patil

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suyash M. Patil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suyash M. Patil. The network helps show where Suyash M. Patil may publish in the future.

Co-authorship network of co-authors of Suyash M. Patil

This figure shows the co-authorship network connecting the top 25 collaborators of Suyash M. Patil. A scholar is included among the top collaborators of Suyash M. Patil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suyash M. Patil. Suyash M. Patil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Patil, Suyash M., et al.. (2025). 3D spheroid model reveals enhanced efficacy of mannose-decorated nanoparticles for TB treatment. Nanomedicine. 20(8). 777–789. 2 indexed citations
2.
Patil, Suyash M., et al.. (2024). A quality-by-design strategic approach for the development of bedaquiline-pretomanid nanoparticles as inhalable dry powders for TB treatment. International Journal of Pharmaceutics. 653. 123920–123920. 9 indexed citations
3.
Patil, Suyash M., et al.. (2024). Design of Experiment (DoE) Approach for Developing Inhalable PLGA Microparticles Loaded with Clofazimine for Tuberculosis Treatment. Pharmaceuticals. 17(6). 754–754. 6 indexed citations
4.
Patil, Suyash M., et al.. (2024). Oral inhalation of dacomitinib nanocarriers as a therapeutic strategy for non-small cell lung cancer. Nanomedicine. 19(18-20). 1601–1613. 1 indexed citations
5.
Patil, Suyash M., et al.. (2023). Pulmonary delivery of spray-dried Nisin ZP antimicrobial peptide for non-small cell lung cancer (NSCLC) treatment. International Journal of Pharmaceutics. 634. 122641–122641. 10 indexed citations
6.
Patil, Suyash M., et al.. (2023). Solubility Enhancement and Inhalation Delivery of Cyclodextrin-Based Inclusion Complex of Delamanid for Pulmonary Tuberculosis Treatment. AAPS PharmSciTech. 24(1). 49–49. 10 indexed citations
7.
Patil, Suyash M. & Nitesh K. Kunda. (2022). Nisin ZP, an Antimicrobial Peptide, Induces Cell Death and Inhibits Non-Small Cell Lung Cancer (NSCLC) Progression in vitro in 2D and 3D Cell Culture. Pharmaceutical Research. 39(11). 2859–2870. 29 indexed citations
8.
Patil, Suyash M. & Nitesh K. Kunda. (2022). Anticancer activity of D-LAK-120A, an antimicrobial peptide, in non-small cell lung cancer (NSCLC). Biochimie. 201. 7–17. 9 indexed citations
9.
Vartak, Richa, Suyash M. Patil, Aishwarya Saraswat, et al.. (2021). Aerosolized Nanoliposomal Carrier of Remdesivir: An Effective Alternative for COVID-19 Treatment In Vitro. Nanomedicine. 16(14). 1187–1202. 63 indexed citations
10.
Patil, Suyash M., et al.. (2021). Pulmonary delivery of osimertinib liposomes for non-small cell lung cancer treatment: formulation development and in vitro evaluation. Drug Delivery and Translational Research. 12(10). 2474–2487. 30 indexed citations
11.
Patil, Suyash M., et al.. (2021). Inhalable bedaquiline-loaded cubosomes for the treatment of non-small cell lung cancer (NSCLC). International Journal of Pharmaceutics. 607. 121046–121046. 50 indexed citations
12.
Petkar, Kailash C., Suyash M. Patil, Sandip S. Chavhan, et al.. (2021). An Overview of Nanocarrier-Based Adjuvants for Vaccine Delivery. Pharmaceutics. 13(4). 455–455. 64 indexed citations
13.
Patil, Suyash M., et al.. (2020). Exosomes as drug delivery systems: A brief overview and progress update. European Journal of Pharmaceutics and Biopharmaceutics. 154. 259–269. 142 indexed citations
14.
Patil, Suyash M., et al.. (2020). Microbes as Medicines: Harnessing the Power of Bacteria in Advancing Cancer Treatment. International Journal of Molecular Sciences. 21(20). 7575–7575. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026